This presentation will focus on the extensive body of evidence that now exists to justify the routine use of nutrigenetic and pharmacogenetic tests in clinical practice.  Whilst it has taken longer than was initially expected, when the first draft of the human genome was published in 2003, the time is now right for the widespread adoption of genomics tests.  What are some of the obstacles and barriers to entry that preclude medical practitioners from utilising this technology?

CPD Points: 0.5